Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic therapies for sickle cell disease
Erica B. Esrick, Daniel E. Bauer
Seminars in Hematology (2018) Vol. 55, Iss. 2, pp. 76-86
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Gene Therapy Leaves a Vicious Cycle
Reena Goswami, G. Mani Subramanian, Liliya Silayeva, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 307
Recent Advances in the Treatment of Sickle Cell Disease
Gabriel Salinas Cisneros, Swee Lay Thein
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 163
Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates
Olivier Humbert, Stefan Radtke, Clare Samuelson, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 503
Open Access | Times Cited: 102
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
Falak Sher, Mir Ahamed Hossain, Davide Seruggia, et al.
Nature Genetics (2019) Vol. 51, Iss. 7, pp. 1149-1159
Open Access | Times Cited: 98
Sickle cell disease: a review for the internist
Valeria Maria Pinto, Manuela Balocco, Sabrina Quintino, et al.
Internal and Emergency Medicine (2019) Vol. 14, Iss. 7, pp. 1051-1064
Closed Access | Times Cited: 88
Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
KATE JOHNSON, Boshen Jiao, Scott D. Ramsey, et al.
Blood Advances (2022) Vol. 7, Iss. 3, pp. 365-374
Open Access | Times Cited: 55
Sickle Cell Disease, a Review
Cameron K. Tebbi
Hemato (2022) Vol. 3, Iss. 2, pp. 341-366
Open Access | Times Cited: 42
Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease
Erdem Kucukal, Yuncheng Man, Ailis Hill, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 11, pp. 1246-1256
Open Access | Times Cited: 53
Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells
Rkia El-Kharrag, Kurt Berckmueller, Ravishankar Madhu, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2186-2198
Open Access | Times Cited: 28
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Selami Demirci, Alexis Leonard, Juan J. Haro‐Mora, et al.
Advances in experimental medicine and biology (2019), pp. 37-52
Closed Access | Times Cited: 52
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion
Shin‐Young Park, Alessandro Mattè, Yookyung Jung, et al.
Blood (2020) Vol. 135, Iss. 23, pp. 2071-2084
Open Access | Times Cited: 47
Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
Alexis Leonard, John F. Tisdale, Allistair Abraham
British Journal of Haematology (2020) Vol. 189, Iss. 3, pp. 408-423
Open Access | Times Cited: 39
Microfluidic electrical impedance assessment of red blood cell-mediated microvascular occlusion
Yuncheng Man, Debnath Maji, Ran An, et al.
Lab on a Chip (2021) Vol. 21, Iss. 6, pp. 1036-1048
Open Access | Times Cited: 34
The genetics of human hematopoiesis and its disruption in disease
Erik L. Bao, Aaron Cheng, Vijay G. Sankaran
EMBO Molecular Medicine (2019) Vol. 11, Iss. 8
Open Access | Times Cited: 42
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE
Alessandro Mattè, Filippo Mazzi, Enrica Federti, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Hematopoietic Cell Transplantation for Sickle Cell Disease
Lakshmanan Krishnamurti
Frontiers in Pediatrics (2021) Vol. 8
Open Access | Times Cited: 28
Hematopoietic Stem Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
Claire Drysdale, Tina Nassehi, Jackson Gamer, et al.
Cell stem cell (2021) Vol. 28, Iss. 2, pp. 191-208
Open Access | Times Cited: 27
A critical review of therapeutic interventions in sickle cell disease: Progress and challenges
Ala Chandu, Renuka Parshuram Joshi, Pragya Gupta, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Open Access | Times Cited: 2
Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
Yvette C. Tanhehco, Monica Bhatia
Current Opinion in Hematology (2019) Vol. 26, Iss. 6, pp. 448-452
Closed Access | Times Cited: 19
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment?
Alessandro Mattè, Maria Domenica Cappellini, Achille Iolascon, et al.
Expert Opinion on Investigational Drugs (2019) Vol. 29, Iss. 1, pp. 23-31
Closed Access | Times Cited: 17
Delta‐globin gene expression improves sickle cell disease in a humanised mouse model
Susanna Porcu, Michela Simbula, Maria Franca Marongiu, et al.
British Journal of Haematology (2021) Vol. 193, Iss. 6, pp. 1228-1237
Open Access | Times Cited: 13
Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease
Yan Zheng, Stella T. Chou
Clinics in Laboratory Medicine (2020) Vol. 41, Iss. 1, pp. 101-119
Open Access | Times Cited: 13
Physiology, Fetal Hemoglobin
Daniel P. Kaufman, Jasmin Khattar, Sarah L. Lappin
StatPearls (2019)
Closed Access | Times Cited: 11
Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance–A retrospective cohort study
Scott D. Ramsey, M. A. Bender, Li Li, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0278137-e0278137
Open Access | Times Cited: 7
A Growing Population of Older Adults with Sickle Cell Disease
Arun S. Shet, Swee Lay Thein
Clinics in Geriatric Medicine (2019) Vol. 35, Iss. 3, pp. 349-367
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top